Prosecution Insights
Last updated: October 04, 2026

BIOMEDIX, S.A.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

BIOMEDIX, S.A. has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is assigned to 1 distinct examiner, TRAN, NHU, who is the busiest examiner with 1 busiest examiner pending action. The matter is currently in 1 distinct art unit, indicating a very specific area of focus for the company.

The portfolio's current state involves 1 pending office action and 1 distinct examiner, which means the company's prosecution activity is highly centralized. This concentration in 1 distinct art unit allows the team to tailor its arguments specifically to the expectations of TRAN, NHU. There is no need to manage multiple examiner relationships or varying art unit procedures at this time. This singular focus in the Medical Devices & Mechanical Engineering area suggests a targeted approach to patenting. The results of this 1 pending action will be the primary measure of the company's current success in securing patent rights.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
1
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TRAN, NHU 1 68.4% +17.5%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18840536 METHODS AND DEVICES FOR MEDICAL IMPLANTS TRAN, NHU 7d

Top Art Units

Art UnitApps
3781 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18840536 METHODS AND DEVICES FOR MEDICAL IMPLANTS TRAN, NHU 3781 §103 Final Rejection 7d Pending Aug 22, 2024

Managing BIOMEDIX, S.A.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month